Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 21, 16:00
218.50
-2.5 (-1.13%)
VOLUME 15,757
LIVE
NSE
Jun 21, 15:59
218.15
-3.4 (-1.53%)
VOLUME 74,870
Announcements on Advanced Enzyme

21st-Jun-2018 11:52Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication - Notice to Equity Shareholders of the Company regarding transfer of Unclaimed Shares to IEPF Demat Account

19th-Jun-2018 10:08Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst / Institutional Investor Meeting

12th-Jun-2018 16:17Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst/Institutional Investor Meeting

8th-Jun-2018 13:38Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst / Institutional Investor Meeting

7th-Jun-2018 11:51Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst / Institutional Investor Meeting

7th-Jun-2018 11:16Source: NSE

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding allotment of 1050 Equity Shares under ESOP

7th-Jun-2018 09:57Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Allotment

Allotment Committee of the Board of Directors of the Company has today allotted 1,050 equity shares of face value of Rs. 2/- pursuant to exercise of options by the eligible employees under the Company...

4th-Jun-2018 11:49Source: BSE

Advanced Enzyme Technologies- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst / Institutional Investor Meeting

29th-May-2018 14:34Source: BSE

Advanced Enzyme Technologies- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakant Rathi Innovations & Projects Pvt Ltd

23rd-May-2018 12:59Source: BSE

Advanced Enzyme Technologies- Transcript Of Earnings Conference Call Dated May 21, 2018

Advanced Enzyme Technologies Limited Q4-FY18 Earnings Conference Call Transcript dated May 21, 2018

1 2 3 4 5 Next >>
Quick Links for Advanced Enzyme Technologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.